1-10 of 10
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry FeatureLatest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Operational Considerations for Bispecific T-Cell Engager Therapies
Medical Industry FeatureOperational Considerations for Bispecific T-Cell Engager Therapies
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry FeatureNew Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry FeatureRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
Medical Industry FeatureManaging Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
- advertisement
Advancing Care in Pretreated HR+/HER2- mBC
Medical Industry FeatureAdvancing Care in Pretreated HR+/HER2- mBC
Supportive Care in Patients with Pretreated HR+/HER2- mBC
Medical Industry FeatureSupportive Care in Patients with Pretreated HR+/HER2- mBC
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry FeatureClinical Decision Making for HER2 Low Metastatic Breast Cancer
Key Considerations for G-CSF Administration in Patients with FN Risk
Medical Industry FeatureKey Considerations for G-CSF Administration in Patients with FN Risk
- advertisement
